Impact of Donor-Derived CD34+Infused Cell Dose on Outcomes of Patients Undergoing Allo-HCT Following Reduced Intensity Regimen for Myelofibrosis:a Study from the Chronic Malignancies Working Party of the EBMT

Affiliation auteurs!!!! Error affiliation !!!!
TitreImpact of Donor-Derived CD34+Infused Cell Dose on Outcomes of Patients Undergoing Allo-HCT Following Reduced Intensity Regimen for Myelofibrosis:a Study from the Chronic Malignancies Working Party of the EBMT
Type de publicationJournal Article
Year of Publication2019
AuteursCzerw T, Malpassuti V, Iacobelli S, Koster L, Kroeger N, Robin M, Maertens J, Chevallier P, Mielke S, Poire X, Snowden JA, Petersen EJ, Malladi R, Blaise D, Remenyi P, Gandemer V, Cammenga J, Rubio MTherese, Maury S, Deconinck E, Finnegan D, Hayden P, Boluda JCarlos Her, McLornan DP, Yakoub-Agha I
JournalBLOOD
Volume134
Date PublishedNOV 13
Type of ArticleMeeting Abstract
ISSN0006-4971
DOI10.1182/blood-2019-123827